نتایج جستجو برای: hoct1

تعداد نتایج: 63  

Journal: :Blood 2009
Dong Hwan Dennis Kim Wei Xu Clement Ma Xiangdong Liu Katherine Siminovitch Hans A Messner Jeffrey H Lipton

Chronic myeloid leukemia (CML) is a clonal myeloproliferative disorder, characterized by the presence of BCR/ABL fusion gene. It is unclear which cellular events drive BCR/ABL gene translocation or initiate leukemogenesis in CML. Bcl-2 promotes survival of hematopoietic stem cells. Accordingly, apoptosis-related pathway may involve in the leukemogenesis of CML. In the current study, we evaluate...

Journal: :The Journal of pharmacology and experimental therapeutics 2007
Ying Chen Shuzhong Zhang Marco Sorani Kathleen M Giacomini

Paraquat (N,N-dimethyl-4-4'-bipiridinium; PQ), a widely used herbicide, when ingested accidentally or intentionally can cause major organ toxicities in lung, liver, and kidney. Because PQ is primarily eliminated in the kidney, renal elimination, including tubular transport, plays a critical role in controlling systemic exposure to the herbicide. The goal of this study was to determine the molec...

Journal: :Molecular pharmaceutics 2013
Giuliano Ciarimboli Rita Schröter Ute Neugebauer Beate Vollenbröker Gert Gabriëls Hrvoje Brzica Ivan Sabolić Gesine Pietig Hermann Pavenstädt Eberhard Schlatter Bayram Edemir

Kidney transplanted patients are often treated with immunosuppressive, antihypertensive, and antibiotic drugs such as cyclosporine A (CsA), β-blockers, and fluoroquinolones, respectively. Organic cation transporters (OCT) expressed in the basolateral membrane of proximal tubules represent an important drug excretion route. In this work, the renal expression of OCT after syngeneic and allogeneic...

Journal: :Molecular pharmacology 2005
Wendy M Suhre Sean Ekins Cheng Chang Peter W Swaan Stephen H Wright

Organic cation transporters are important for the elimination of many drugs and toxins from the body. In the present study, substrate-transporter interactions were investigated in Chinese hamster ovary cells stably transfected with either the human or rabbit orthologs of the principal organic cation transporter in the kidney, OCT2. IC(50) values, ranging from 0.04 muM to >3 mM, for inhibition o...

Journal: :Drug metabolism and disposition: the biological fate of chemicals 2009
Ken-ichi Umehara Nobuaki Shirai Takafumi Iwatsubo Kiyoshi Noguchi Takashi Usui Hidetaka Kamimura

(-)-N-{2-[(R)-3-(6,7-Dimethoxy-1,2,3,4-tetrahydroisoquinoline-2-carbonyl)piperidino]ethyl}-4-fluorobenzamide (YM758) is a novel inhibitor of the "funny" If current channel (If channel) that is expressed in the sinus node of heart and is being developed as a treatment for stable angina and atrial fibrillation. Its metabolites were identified in human urine, plasma, and feces by radio-high-perfor...

Journal: :The Journal of pharmacology and experimental therapeutics 2012
Sumito Ito Hiroyuki Kusuhara Miyu Yokochi Junko Toyoshima Katsuhisa Inoue Hiroaki Yuasa Yuichi Sugiyama

Cimetidine, an H₂ receptor antagonist, has been used to investigate the tubular secretion of organic cations in human kidney. We report a systematic comprehensive analysis of the inhibition potency of cimetidine for the influx and efflux transporters of organic cations [human organic cation transporter 1 (hOCT1) and hOCT2 and human multidrug and toxin extrusion 1 (hMATE1) and hMATE2-K, respecti...

Journal: :Drug metabolism and disposition: the biological fate of chemicals 2010
Tomoya Yasujima Kin-ya Ohta Katsuhisa Inoue Munenori Ishimaru Hiroaki Yuasa

Multidrug and toxin extrusion protein 1 (MATE1) and MATE2-K are organic cation/H(+) antiporters that have recently been identified and suggested to be responsible for the brush border secretory transport of many cationic drugs in renal tubules. We here report our finding that 4',6-diamidino-2-phenylindole (DAPI) can be used as a probe substrate for rapid assays of the functionality of the human...

2013
Brandon Swift Noelia Nebot Jin Kyung Lee Tianxiang Han William R. Proctor Dhiren R. Thakker Dieter Lang Martin Radtke Mark J. Gnoth Kim L. R. Brouwer

Sorafenib is an orally active tyrosine kinase inhibitor used in the treatment of renal and hepatocellular carcinoma. This study was designed to establish whether transport proteins are involved in the hepatic uptake of sorafenib and to determine the extent of biliary excretion of sorafenib and its metabolites in human hepatocytes. Initial uptake was assessed in freshly isolated, suspended human...

2015
Jia Yin Haichuan Duan Yoshiyuki Shirasaka Bhagwat Prasad Joanne Wang

Atenolol is a b-blocker widely used in the treatment of hypertension. Atenolol is cleared predominantly by the kidney by both glomerular filtration and active secretion, but the molecular mechanisms involved in its renal secretion are unclear. Using a panel of human embryonic kidney cell lines stably expressing human organic cation transporter (hOCT) 1–3, human organic anion transporter (hOAT) ...

Journal: :Drug metabolism and disposition: the biological fate of chemicals 2013
Brandon Swift Noelia Nebot Jin Kyung Lee Tianxiang Han William R Proctor Dhiren R Thakker Dieter Lang Martin Radtke Mark J Gnoth Kim L R Brouwer

Sorafenib is an orally active tyrosine kinase inhibitor used in the treatment of renal and hepatocellular carcinoma. This study was designed to establish whether transport proteins are involved in the hepatic uptake of sorafenib and to determine the extent of biliary excretion of sorafenib and its metabolites in human hepatocytes. Initial uptake was assessed in freshly isolated, suspended human...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید